Short contact therapy with tazarotene in psoriasis vulgaris

Stefano Veraldi, Ruggero Caputo, Alessia Pacifico, Ketty Peris, Rosario Soda, Sergio Chimenti

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: We present the results of a multicentre, not controlled, clinical study on the tolerability and efficacy of tazarotene gel, used as short contact therapy (SCT), in psoriasis vulgaris. Objective: To evaluate whether irritant contact dermatitis caused by tazarotene was less frequent and/or less severe with SCT than with traditional therapy, and whether SCT with tazarotene was as effective as traditional therapy. Methods: Forty-three patients with plaque psoriasis were treated by SCT with 0.1% tazarotene gel (once daily application for 20 min, followed by washing with water). Treatment duration was 45 days. Results: Irritant contact dermatitis caused by tazarotene used as SCT was much less frequent and severe than traditional treatment with the same drug. SCT with tazarotene was effective in the treatment of plaque psoriasis. Conclusion: Tazarotene, used as SCT, was better tolerated than the same drug used as traditional treatment. Furthermore, SCT appeared to be as effective as traditional therapy with the same drug.

Original languageEnglish
Pages (from-to)235-237
Number of pages3
JournalDermatology
Volume212
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Psoriasis
Therapeutics
Irritant Dermatitis
Contact Dermatitis
tazarotene
Gels
Pharmaceutical Preparations

Keywords

  • Contact dermatitis, irritant
  • Contact therapy, short
  • Psoriasis vulgaris
  • Tazarotene

ASJC Scopus subject areas

  • Dermatology

Cite this

Veraldi, S., Caputo, R., Pacifico, A., Peris, K., Soda, R., & Chimenti, S. (2006). Short contact therapy with tazarotene in psoriasis vulgaris. Dermatology, 212(3), 235-237. https://doi.org/10.1159/000091250

Short contact therapy with tazarotene in psoriasis vulgaris. / Veraldi, Stefano; Caputo, Ruggero; Pacifico, Alessia; Peris, Ketty; Soda, Rosario; Chimenti, Sergio.

In: Dermatology, Vol. 212, No. 3, 03.2006, p. 235-237.

Research output: Contribution to journalArticle

Veraldi, S, Caputo, R, Pacifico, A, Peris, K, Soda, R & Chimenti, S 2006, 'Short contact therapy with tazarotene in psoriasis vulgaris', Dermatology, vol. 212, no. 3, pp. 235-237. https://doi.org/10.1159/000091250
Veraldi S, Caputo R, Pacifico A, Peris K, Soda R, Chimenti S. Short contact therapy with tazarotene in psoriasis vulgaris. Dermatology. 2006 Mar;212(3):235-237. https://doi.org/10.1159/000091250
Veraldi, Stefano ; Caputo, Ruggero ; Pacifico, Alessia ; Peris, Ketty ; Soda, Rosario ; Chimenti, Sergio. / Short contact therapy with tazarotene in psoriasis vulgaris. In: Dermatology. 2006 ; Vol. 212, No. 3. pp. 235-237.
@article{9c2a4be7fb44416fa5a038c43a98e6a2,
title = "Short contact therapy with tazarotene in psoriasis vulgaris",
abstract = "Background: We present the results of a multicentre, not controlled, clinical study on the tolerability and efficacy of tazarotene gel, used as short contact therapy (SCT), in psoriasis vulgaris. Objective: To evaluate whether irritant contact dermatitis caused by tazarotene was less frequent and/or less severe with SCT than with traditional therapy, and whether SCT with tazarotene was as effective as traditional therapy. Methods: Forty-three patients with plaque psoriasis were treated by SCT with 0.1{\%} tazarotene gel (once daily application for 20 min, followed by washing with water). Treatment duration was 45 days. Results: Irritant contact dermatitis caused by tazarotene used as SCT was much less frequent and severe than traditional treatment with the same drug. SCT with tazarotene was effective in the treatment of plaque psoriasis. Conclusion: Tazarotene, used as SCT, was better tolerated than the same drug used as traditional treatment. Furthermore, SCT appeared to be as effective as traditional therapy with the same drug.",
keywords = "Contact dermatitis, irritant, Contact therapy, short, Psoriasis vulgaris, Tazarotene",
author = "Stefano Veraldi and Ruggero Caputo and Alessia Pacifico and Ketty Peris and Rosario Soda and Sergio Chimenti",
year = "2006",
month = "3",
doi = "10.1159/000091250",
language = "English",
volume = "212",
pages = "235--237",
journal = "Dermatology",
issn = "1018-8665",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Short contact therapy with tazarotene in psoriasis vulgaris

AU - Veraldi, Stefano

AU - Caputo, Ruggero

AU - Pacifico, Alessia

AU - Peris, Ketty

AU - Soda, Rosario

AU - Chimenti, Sergio

PY - 2006/3

Y1 - 2006/3

N2 - Background: We present the results of a multicentre, not controlled, clinical study on the tolerability and efficacy of tazarotene gel, used as short contact therapy (SCT), in psoriasis vulgaris. Objective: To evaluate whether irritant contact dermatitis caused by tazarotene was less frequent and/or less severe with SCT than with traditional therapy, and whether SCT with tazarotene was as effective as traditional therapy. Methods: Forty-three patients with plaque psoriasis were treated by SCT with 0.1% tazarotene gel (once daily application for 20 min, followed by washing with water). Treatment duration was 45 days. Results: Irritant contact dermatitis caused by tazarotene used as SCT was much less frequent and severe than traditional treatment with the same drug. SCT with tazarotene was effective in the treatment of plaque psoriasis. Conclusion: Tazarotene, used as SCT, was better tolerated than the same drug used as traditional treatment. Furthermore, SCT appeared to be as effective as traditional therapy with the same drug.

AB - Background: We present the results of a multicentre, not controlled, clinical study on the tolerability and efficacy of tazarotene gel, used as short contact therapy (SCT), in psoriasis vulgaris. Objective: To evaluate whether irritant contact dermatitis caused by tazarotene was less frequent and/or less severe with SCT than with traditional therapy, and whether SCT with tazarotene was as effective as traditional therapy. Methods: Forty-three patients with plaque psoriasis were treated by SCT with 0.1% tazarotene gel (once daily application for 20 min, followed by washing with water). Treatment duration was 45 days. Results: Irritant contact dermatitis caused by tazarotene used as SCT was much less frequent and severe than traditional treatment with the same drug. SCT with tazarotene was effective in the treatment of plaque psoriasis. Conclusion: Tazarotene, used as SCT, was better tolerated than the same drug used as traditional treatment. Furthermore, SCT appeared to be as effective as traditional therapy with the same drug.

KW - Contact dermatitis, irritant

KW - Contact therapy, short

KW - Psoriasis vulgaris

KW - Tazarotene

UR - http://www.scopus.com/inward/record.url?scp=33645214422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645214422&partnerID=8YFLogxK

U2 - 10.1159/000091250

DO - 10.1159/000091250

M3 - Article

VL - 212

SP - 235

EP - 237

JO - Dermatology

JF - Dermatology

SN - 1018-8665

IS - 3

ER -